[Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019]
H Boboli1, F Boemer2, M Mastouri1
1Service de Pneumologie Pédiatrique, Département de Pédiatrie, CHU de Liège, Belgique.
Insights
Belgium will implement neonatal screening for cystic fibrosis by the end of 2019. This initiative aims to improve early diagnosis and patient outcomes for this genetic disorder.
Area of Science:
- Medical Genetics
- Pediatrics
- Public Health
Background:
- Cystic fibrosis (CF) affects 1 in 2,850 births in Belgium.
- Current diagnosis relies on clinical signs and symptoms, with a median age of 7 months.
- Scientific evidence supports the benefits of early detection through neonatal screening.
Purpose of the Study:
- To outline the upcoming implementation of a national neonatal screening program for cystic fibrosis in Belgium.
- To emphasize the importance of establishing strict quality criteria for the screening program.
- To ensure optimal performance and minimize patient inconvenience.
Main Methods:
- The abstract does not detail specific methods but refers to the implementation of a screening program.
- Quality criteria will be developed to frame the screening initiative.
- Data from the Belgian registry (2015) informs the prevalence and diagnosis age.
Main Results:
- Neonatal screening for cystic fibrosis is set to be implemented in Belgium by the end of 2019.
- The program aims to improve early diagnosis compared to symptom-based detection.
- Strict quality criteria are essential for program success.
Conclusions:
- The implementation of neonatal screening represents a significant advancement in cystic fibrosis care in Belgium.
- Establishing robust quality standards will be crucial for the program's effectiveness.
- Early detection through screening is expected to enhance patient management and long-term outcomes.
Abstract:
Cystic fibrosis has in Belgium a prevalence of 1/2.850 births, with a median age at diagnosis of 7 months according to the latest data from the Belgian registry of 2015. In our country, the diagnosis of cystic fibrosis is always based on signs and symptoms of the disease. However, because the scientific literature has largely demonstrated the benefits of neonatal screening for cystic fibrosis, it will be implemented in Belgium before the end of 2019. The screening programme should be framed by strict quality criteria in order to obtain the best performance with the least possible inconvenience.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
SI Units: 2019 Redefinition
A standard set of units has been defined...
National Nursing Organizations I
National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
Nursing Implementation
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.


